Immuneering (IMRX) Return on Sales (2020 - 2023)
Historic Return on Sales for Immuneering (IMRX) over the last 4 years, with Q3 2023 value amounting to 115883.27%.
- Immuneering's Return on Sales fell 1155454600.0% to 115883.27% in Q3 2023 from the same period last year, while for Sep 2023 it was 115883.27%, marking a year-over-year decrease of 1157879600.0%. This contributed to the annual value of 159.37% for FY2022, which is 1432500.0% down from last year.
- Per Immuneering's latest filing, its Return on Sales stood at 115883.27% for Q3 2023, which was down 1155454600.0% from 1355.0% recorded in Q2 2023.
- In the past 5 years, Immuneering's Return on Sales registered a high of 6.44% during Q3 2020, and its lowest value of 115883.27% during Q3 2023.
- In the last 4 years, Immuneering's Return on Sales had a median value of 63.76% in 2021 and averaged 10562.62%.
- As far as peak fluctuations go, Immuneering's Return on Sales tumbled by -46100bps in 2021, and later crashed by -1155454600bps in 2023.
- Immuneering's Return on Sales (Quarter) stood at 8.77% in 2020, then plummeted by -560bps to 57.88% in 2021, then crashed by -51047bps to 29601.84% in 2022, then plummeted by -291bps to 115883.27% in 2023.
- Its Return on Sales was 115883.27% in Q3 2023, compared to 1355.0% in Q2 2023 and 388.62% in Q1 2023.